Enfusion, Inc. (ENFN)
After hours:
| Previous Close | 9.52 |
| Open | 9.56 |
| Bid | 8.95 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 9.13 - 9.69 |
| 52 Week Range | 7.80 - 21.74 |
| Volume | |
| Avg. Volume | 292,716 |
| Market Cap | 638.811M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings Date | Nov 10, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.40 |
- Business Wire
Enfusion Welcomes New Addition to Board of Directors
NEW YORK & LONDON & HONG KONG, November 30, 2022--Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, today announced the appointment of global asset management and financial industry veteran Deirdre Somers to its Board of Directors, effective January 1, 2023. As part of her role, she will sit on the Audit and the Nominating and Corporate Governance Committees.
- Business Wire
Enfusion Announces Resignation of Chief Financial Officer
NEW YORK & LONDON & HONG KONG, November 28, 2022--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced that Stephen Dorton has resigned from his position as Chief Financial Officer, effective January 6, 2023, in order to pursue another career opportunity, and not due to any disagreement with Enfusion’s operations, policies or practices.
- Simply Wall St.
Enfusion Third Quarter 2022 Earnings: Beats Expectations
Enfusion ( NYSE:ENFN ) Third Quarter 2022 Results Key Financial Results Revenue: US$39.2m (up 35% from 3Q 2021). Net...
